Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gong An Kang (宫安康) is a brand name for 宫腔用交联透明质酸钠凝胶 (Uterine Cavity Cross-linked Sodium Hyaluronate Gel), a Class III medical device manufactured by Changzhou Bairuiji Biomedical Co., Ltd. It is composed of cross-linked sodium hyaluronate, sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, and water for injection. This sterile, transparent, and highly viscous gel is primarily used to prevent or reduce intrauterine adhesions following hysteroscopy and other intrauterine surgeries. It also aids in protecting the endometrium, reducing the risk of miscarriage, and assisting in artificial insemination by creating a favorable environment for implantation. The gel is designed to be absorbed by the body within approximately 30 days.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 宫腔用交联透明质酸钠凝胶.